Associated Papers
Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system.
Wagner JT et al.
Frontiers in Molecular Biosciences, 2025
41158875 (PubMed )
Supplement: DataSheet1.xlsx › D
AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Leclerc J et al.
Genes, Chromosomes & Cancer, 2023
36502525 (PubMed )
Supplement: GCC-62-210-s001.xlsx › AXIN2_variants
Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL et al.
Plos One, 2018
29641532 (PubMed )
Supplement: pone.0194098.s003.xlsx › UK10K_TSG
AXIN2 Polymorphisms, the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility.
Aristizabal-Pachon AF et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
Identification of genetic alterations of AXIN2 gene in adrenocortical tumors.
Chapman A et al.
The Journal of Clinical Endocrinology and Metabolism, 2011
AXIN2 germline mutations are rare in familial melanoma.
Pedace L et al.
Genes, Chromosomes & Cancer, 2011
Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
Castiglia D et al.
Genes, Chromosomes & Cancer, 2008
Select a paper to view details